Table 1 Lung asbestos content in mesothelioma cases versus controls
From: A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases
Mesothelioma n = 95 (65.52%) | Controls n = 50 (34.48%) | p-value | p-value ^ | |
|---|---|---|---|---|
Mean (standard deviation) | ||||
Asbestos concentration (ff/gdw) | 79705.59 (240333.83) | 3187.74 (7582.45) | 0.0025 | 0.0002 |
Concentration of asbestos bodies (ff/gdw) | 74670.71 (333130.60) | 2013.54 (5627.97) | 0.0362 | 0.0137 |
Concentration of Chrysotile asbestiform antigorite (ff/gdw) | 433.78 (1886.95) | 488.85 (2131.73) | 0.8734 | 0.8181 |
Concentration of crocidolite (ff/gdw) | 32343.66 (102023.53) | 0 (0) | 0.0026 | 0.1557 |
Concentration of amosite (ff/gdw) | 38522.37 (142833.63) | 123.04 (870.05) | 0.0102 | 0.0051 |
Concentration of anthophyllite asbestos (ff/gdw) | 676.27 (3471.68) | 257.27 (1819.19) | 0.3419 | 0.3925 |
Concentration of tremolite actinolite asbestos (ff/gdw) | 7729.52 (13009.02) | 2318.58 (5979.66) | 0.0008 | 0.0054 |
Mean length of asbestos fibers (μm) | 23.87 (12.42) | 19.87 (14.99) | 0.2929 | 0.2749 |
Mean width of asbestos fibers (μm) | 0.68 (0.28) | 0.96 (0.38) | 0.0027 | 0.0070 |
Survival (months) | 17.40 (14.74) | – | – | – |